We estimate that there will be 13· 7 million new cases of childhood cancer globally between
2020 and 2050. At current levels of health system performance (including access and …

Approximately 20% of children with hepatoblastoma (HB) have metastatic disease at
diagnosis, most frequently in the lungs. In children with HB, lung metastatic disease is …

Background Hepatoblastoma is the most common liver malignancy in the pediatric age
group. The management of hepatoblastoma involves multidisciplinary approach. Methods …

Liver tumors in children are uncommon and show remarkable morphologic heterogeneity.
Pediatric tumors may arise from either the epithelial or mesenchymal component of the liver …

LT has contributed to an elevation in cure rates for patients with unresectable HB; however,
patients with recurrent HB after LT have poor prognosis. To analyze the prognostic and …

Background Information on the epidemiology of pediatric liver tumors in Latin America is
limited. Purpose To describe the incidence of liver tumors in a pediatric registry in Argentina …

Objectives: State the epidemiology of hepatoblastomas. Explain treatment considerations for
patients with hepatoblastomas. Describe the presentation of a patient with a …

Objective The present study aimed to summarize the clinical data of hepatoblastoma (HB) in
infants under one year of age and to analyze the factors that affected the prognoses …

Background: Hepatoblastoma is rare cancer that responds well to risk-based chemotherapy,
and surgical treatment is needed to achieve complete remission and satisfactory survival …

Materials and Methods: Herein, diethylnitrosamine and thioacetamide (TAA) were used to
develop stage-specific HCC in Wistar rats. Histopathological changes, biochemical …